escitalopram oxalate
- Product NDC
- 68071-3265
- 11-digit product format
- 680713265
- Labeler code
- 68071
- Product ID
- 68071-3265_e11b27ab-5a2b-76c4-e053-2a95a90a7293
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- escitalopram oxalate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA090939
- Marketing category
- ANDA
- Marketing start
- 2012-09-11
- Marketing end
- 0000-00-00
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 68071-3265-2 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
| 68071-3265-3 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
| 68071-3265-9 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
| 68071-3265-2 | 2020-07-21 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
| 68071-3265-3 | 2020-07-21 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
| 68071-3265-9 | 2020-07-21 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
| 68071-3265-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
| 68071-3265-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
| 68071-3265-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-828d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. ESCITALOPRAM tablets USP, for oral use Initial U.S. Approval: 2002 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3265-2 | escitalopram oxalate | 20 in 1 BOTTLE | TABLET | 20 | | 4 |
| 68071-3265-3 | escitalopram oxalate | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
| 68071-3265-9 | escitalopram oxalate | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-3265 | ESCITALOPRAM OXALATE TABLET [NUCARE PHARMACEUTICALS, INC.] | 4 | Legacy NDC, 3 package rows | 20220612_4f434cbc-318b-6554-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-3265-2 | 68071326502 | 20 TABLET in 1 BOTTLE (68071-3265-2) | 20 tablet | 2017-05-11 | 0000-00-00 | No | No | Current |
| 68071-3265-3 | 68071326503 | 30 TABLET in 1 BOTTLE (68071-3265-3) | 30 tablet | 2017-05-11 | 0000-00-00 | No | No | Current |
| 68071-3265-9 | 68071326509 | 90 TABLET in 1 BOTTLE (68071-3265-9) | 90 tablet | 2017-05-11 | 0000-00-00 | No | No | Current |